ABCD trial

ABCD trial

Cardiovascular disease
1. A prospective, randomized, blinded, clinical trial–Appropriate Blood Pressure Control in Diabetes–which compared, in type 2–NIDDM diabetics, 1. The efficacy of nisoldipine, a CCB, with enalapril, an ACE inhibitor, as 1st-line antihypertensive agents and.
2. The effects of moderate BP control–target–80-89 mm Hg vs 'tight' BP control–target–75 mm Hg on cardiovascular M&M. See Enalapril, Nisoldepine.
3. A clinical trial–Alternans Before Cardioverter-Defibrillator.
References in periodicals archive ?
The ABCD Trial found that a non-invasive test called microvolt T-Wave Alternans (which uses computer technology to predict a patient's risk for sudden cardiac death) is comparable to an invasive and more expensive procedure commonly used by cardiac electrophysiologists to determine a patient's eligibility for an implanted defibrillator.
The ABCD trial will give referring physicians a non-invasive means of categorizing a patient's risk," said Eric S.
The ABCD trial, initiated in May 2001, followed 566 patients, 18 years of age and older, at 43 medical centers in the United States, Germany and Israel, for a median of 1.